TL;DR: F0561-0825 (CAS 1019094-60-0) is a chemical compound with molecular formula C21H21N3O5S and molecular weight 427.12018 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
3,4-dimethoxy-N-[2-(4-methoxyphenyl)-5-oxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]benzamide
Also Known As: F0561-0825, 3,4-dimethoxy-N-[2-(4-methoxyphenyl)-5-oxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]benzamide, 3,4-dimethoxy-N-(2-(4-methoxyphenyl)-5-oxido-4,6-dihydro-2H-thieno[3,4-c]pyrazol-3-yl)benzamide, 3,4-dimethoxy-N-[2-(4-methoxyphenyl)-5-oxo-2H,4H,6H-5lambda4-thieno[3,4-c]pyrazol-3-yl]benzamide
| Molecular Formula | C21H21N3O5S |
| Molecular Weight | 427.12018 g/mol |
| XLogP | 1.7 |
| Topological Polar Surface Area (TPSA) | 111.0 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Exact Mass | 427.12018 Da |
| Heavy Atoms | 30 |
| Complexity | 630.0 |
| SMILES | COC1=CC=C(C=C1)N2C(=C3CS(=O)CC3=N2)NC(=O)C4=CC(=C(C=C4)OC)OC |
| InChIKey | CVDIZUPDKJIZLR-UHFFFAOYSA-N |
The XLogP value of 1.7 suggests moderate lipophilicity, balancing water solubility and membrane permeability for F0561-0825. The TPSA of 111.0 Ų falls within the moderate polarity range, balancing permeability and solubility for F0561-0825. Following Lipinski's Rule of Five, F0561-0825 has 1 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of F0561-0825 is 1019094-60-0.
The molecular formula of F0561-0825 is C21H21N3O5S.
The molecular weight of F0561-0825 is 427.12018 g/mol.
You can request a quote for F0561-0825 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for F0561-0825 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 1019094-60-0. Our professional technical team will respond with pricing and lead time.